Literature DB >> 24912915

A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative.

Gaya Spolverato1, Yuhree Kim, Aslam Ejaz, Vicente Valero, Malcolm H Squires, George Poultsides, Ryan C Fields, Mark Bloomston, Sharon M Weber, Alexandra W Acher, Konstantinos Votanopoulos, Carl Schmidt, Clifford S Cho, Shishir K Maithel, Timothy M Pawlik.   

Abstract

BACKGROUND: Surgical experience with minimally invasive surgery (MIS) has increased; however, published reports on MIS resection of gastric adenocarcinoma are limited.
METHODS: Between 2000 and 2012, 880 patients who underwent surgical resection of gastric adenocarcinoma were identified from a multi-institutional database. Clinicopathological characteristics, operative details, and outcomes were stratified by operative approach (open vs. MIS) and analyzed.
RESULTS: Overall, 70 (8 %) patients had a MIS approach. Patients who underwent a MIS resection were more likely to have a smaller tumor (open 4.5 cm vs. MIS 3.0 cm, p < 0.001). MIS resections were associated with lower estimated blood loss (open 250 cc vs. MIS 150 cc) and longer operative time (open 232 min vs. MIS 271 min) compared with open surgery (both p < 0.05). An R0 resection was achieved in most patients (open 90.9 % vs. MIS 98.6 %, p = 0.03) and median lymph node yield was good in both groups (open 17 vs. MIS 14, p = 0.10). MIS had a similar incidence of complications (open 33.1 % vs. MIS 20 %, p = 0.07) and a similar length of stay (open 9 days vs. MIS 7 days, p = 0.13) compared with open surgery. In the propensity-matched analysis, median recurrence-free and overall were not impacted by operative approach.
CONCLUSION: An MIS approach to gastric cancer was associated with adequate lymph node retrieval, a high incidence of R0 resection, and comparable long-term oncological outcomes versus open gastrectomy.

Entities:  

Mesh:

Year:  2014        PMID: 24912915     DOI: 10.1007/s11605-014-2562-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  51 in total

1.  Effectiveness of paraaortic lymph node dissection for advanced gastric cancer.

Authors:  H Isozaki; K Okajima; K Fujii; E Nomura; N Izumi; H Mabuchi; M Nakamura; H Hara
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  Laparoscopy-assisted Billroth-I gastrectomy (LADG) for cancer: our 10 years' experience.

Authors:  Seigo Kitano; Norio Shiraishi; Kenji Kakisako; Kazuhiro Yasuda; Masafumi Inomata; Yosuke Adachi
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2002-06       Impact factor: 1.719

3.  Open versus laparoscopic cholecystectomy: a retrospective comparative study.

Authors:  M T Glinatsis; J P Griffith; M J McMahon
Journal:  J Laparoendosc Surg       Date:  1992-04

4.  Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients.

Authors:  Moon-Soo Lee; Ju-Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang
Journal:  Surg Endosc       Date:  2013-03-29       Impact factor: 4.584

Review 5.  The evolution of minimally invasive bariatric surgery.

Authors:  Andrew J Batchelder; Robert Williams; Christopher Sutton; Achal Khanna
Journal:  J Surg Res       Date:  2013-03-14       Impact factor: 2.192

6.  Laparoscopy-assisted vs. open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study.

Authors:  T Bo; Y Peiwu; Q Feng; Z Yongliang; S Yan; H Yingxue; L Huaxing
Journal:  J Gastrointest Surg       Date:  2013-05-17       Impact factor: 3.452

7.  Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer.

Authors:  Erito Mochiki; Yoshitaka Toyomasu; Kyouichi Ogata; Hiroyuki Andoh; Tetsuro Ohno; Ryusuke Aihara; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Endosc       Date:  2008-07-02       Impact factor: 4.584

8.  Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma.

Authors:  B Topal; E Leys; N Ectors; R Aerts; F Penninckx
Journal:  Surg Endosc       Date:  2007-08-10       Impact factor: 4.584

Review 9.  Laparoscopic versus open liver resection for benign and malignant hepatic lesions in adults.

Authors:  Ahsan M Rao; Irfan Ahmed
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

10.  Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; A Vendrame; M Tomatis; C Mazza; A Borasi; L Capussotti; G Fronda; M Morino
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939

View more
  6 in total

Review 1.  Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.

Authors:  Stefano Caruso; Alberto Patriti; Franco Roviello; Lorenzo De Franco; Franco Franceschini; Andrea Coratti; Graziano Ceccarelli
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.

Authors:  Norma E Farrow; Kyle W Freischlag; Mohamed A Adam; Dan G Blazer
Journal:  J Surg Oncol       Date:  2020-01-09       Impact factor: 3.454

3.  Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers.

Authors:  Jason A Glenn; Kiran K Turaga; T Clark Gamblin; Samuel F Hohmann; Fabian M Johnston
Journal:  Surg Endosc       Date:  2015-03-20       Impact factor: 4.584

4.  Minimally invasive resection of choledochal cyst: a feasible and safe surgical option.

Authors:  Georgios Antonios Margonis; Gaya Spolverato; Yuhree Kim; Hugo Marques; George Poultsides; Shishir Maithel; Luca Aldrighetti; Todd W Bauer; Nicolas Jabbour; T Clark Gamblin; Kevin Soares; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-12-18       Impact factor: 3.452

5.  Laparoscopic Total Gastrectomy with D2 Lymphadenectomy and Side-to-Side Stapled Esophagojejunostomy.

Authors:  Daniela Treitl; Steven N Hochwald; Philip Q Bao; Joshua M Unger; Kfir Ben-David
Journal:  J Gastrointest Surg       Date:  2016-05-16       Impact factor: 3.452

6.  A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer.

Authors:  Alice Sabrina Tonello; Giulia Capelli; Quoc Riccardo Bao; Alberto Marchet; Fabio Farinati; Timothy M Pawlik; Dario Gregori; Salvatore Pucciarelli; Gaya Spolverato
Journal:  Updates Surg       Date:  2021-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.